Oral contraceptives and pituitary adenomas.
作者信息
Wingrave S J, Kay C R, Vessey M P
出版信息
Br Med J. 1980 Mar 8;280(6215):685-6. doi: 10.1136/bmj.280.6215.685-a.
Abstract
摘要
相似文献
1
Oral contraceptives and pituitary adenomas.口服避孕药与垂体腺瘤
Br Med J. 1980 Mar 8;280(6215):685-6. doi: 10.1136/bmj.280.6215.685-a.
2
Pituitary adenoma and contraceptives.垂体腺瘤与避孕药
Fertil Steril. 1979 Dec;32(6):711.
3
Oral contraceptive exposure in a male with a pituitary microadenoma: a case report.一名患有垂体微腺瘤男性的口服避孕药暴露：病例报告
Contraception. 1977 Oct;16(4):351-6. doi: 10.1016/0010-7824(77)90046-4.
4
Pituitary adenomas and oral contraceptives: a multicenter case-control study.垂体腺瘤与口服避孕药：一项多中心病例对照研究。
Fertil Steril. 1983 Jun;39(6):753-60.
5
Oral contraceptives and cancer.
Lancet. 1972 Oct 28;2(7783):911.
6
Pituitary adenoma and oral contraceptives: a case-control study.垂体腺瘤与口服避孕药：一项病例对照研究。
Fertil Steril. 1979 Jan;31(1):25-8. doi: 10.1016/s0015-0282(16)43754-4.
7
Pituitary adenomas and oral contraceptives.垂体腺瘤与口服避孕药。
Lancet. 1978;2(8104-5):1384.
8
The prolactinoma problem.催乳素瘤问题。
N Engl J Med. 1979 Feb 8;300(6):313-5. doi: 10.1056/NEJM197902083000612.
9
Two studies find no link between use of oral contraceptives and development of pituitary tumors.
Fam Plann Perspect. 1983 Nov-Dec;15(6):283-4.
10
[Oral steroid contraception in hyperprolactinemia (author's transl)].高泌乳素血症中的口服甾体避孕药（作者译）
Geburtshilfe Frauenheilkd. 1981 Mar;41(3):199-203. doi: 10.1055/s-2008-1037355.
引用本文的文献
1
The Effect of Females' Reproductive Factors on Pituitary Gland Size in Women at Reproductive Age.女性生殖因素对育龄妇女垂体大小的影响。
Medicina (Kaunas). 2019 Jul 11;55(7):367. doi: 10.3390/medicina55070367.
2
Pituitary hyperplasia: case series and literature review of an under-recognised and heterogeneous condition.垂体增生：一个未被充分认识且异质性疾病的病例系列及文献综述
Endocrinol Diabetes Metab Case Rep. 2015;2015:150017. doi: 10.1530/EDM-15-0017. Epub 2015 Jun 1.
3
[Treatment of pituitary gland hyperfunction: from acromegaly to prolactinoma].[垂体功能亢进的治疗：从肢端肥大症到泌乳素瘤]
Internist (Berl). 2006 Dec;47(12):1215-6, 1218-20, 1222. doi: 10.1007/s00108-006-1727-3.
4
Long-term management of prolactinomas--use of long-acting dopamine agonists.泌乳素瘤的长期管理——长效多巴胺激动剂的应用
Rev Endocr Metab Disord. 2005 Jan;6(1):15-21. doi: 10.1007/s11154-005-5220-4.
5
PRL-secreting pituitary adenomas in pregnancy.
J Endocrinol Invest. 2003 Jan;26(1):96-9. doi: 10.1007/BF03345132.
6
Functional role of estrogen in pituitary tumor pathogenesis.雌激素在垂体肿瘤发病机制中的功能作用。
J Clin Invest. 2002 Jan;109(2):277-83. doi: 10.1172/JCI14264.
7
Prolactinoma in a man following industrial exposure to estrogens.一名男性在职业性接触雌激素后发生泌乳素瘤。
West J Med. 1983 May;138(5):720-2.
8
Effect of long term hormone replacement on plasma prolactin concentrations in women after oophorectomy.长期激素替代疗法对卵巢切除术后女性血浆催乳素浓度的影响。
Br Med J (Clin Res Ed). 1985 Feb 23;290(6468):589-91. doi: 10.1136/bmj.290.6468.589.
本文引用的文献
1
A long-term follow-up study of women using different methods of contraception--an interim report.一项针对采用不同避孕方法的女性的长期随访研究——中期报告。
J Biosoc Sci. 1976 Oct;8(4):373-427. doi: 10.1017/s0021932000010890.
2
Pituitary adenoma and oral contraceptives: a case-control study.垂体腺瘤与口服避孕药：一项病例对照研究。
Fertil Steril. 1979 Jan;31(1):25-8. doi: 10.1016/s0015-0282(16)43754-4.
3
Pathogenesis of prolactin-secreting pituitary adenomas.
Lancet. 1978 Nov 11;2(8098):1019-21. doi: 10.1016/s0140-6736(78)92339-5.
Zotero 插件